{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-21-005210","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2021-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.385183+00:00","generated_at":"2026-06-28T13:49:08.203544+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Sunshine Biopharma expands board to 5, adds 3 independent directors, aims for Nasdaq uplist","bullets":["Board expanded from 3 to 5 members; added Andrew Telsey (legal), JD Kish (accounting), Dr. Rabi Kiderchah (medical).","Camille Sebaaly resigned as director but remains CFO.","New appointments part of Company's application process to uplist to Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-21-005210","json":"https://secwatch.observer/filing/0001683168-21-005210.json","markdown":"https://secwatch.observer/filing/0001683168-21-005210.md","text":"https://secwatch.observer/filing/0001683168-21-005210.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316821005210/0001683168-21-005210-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316821005210/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T13:49:08.203544+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"17bf4fe67e","claim":"JD Kish was appointed as Director at Sunshine Biopharma Inc..","evidence_excerpt":"The Board added Messrs. Andrew Telsey, JD Kish and Dr. Rabi Kiderchah to serve as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316821005210/0001683168-21-005210-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"added"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e7e641e13a","claim":"Rabi Kiderchah was appointed as Director at Sunshine Biopharma Inc..","evidence_excerpt":"The Board added Messrs. Andrew Telsey, JD Kish and Dr. Rabi Kiderchah to serve as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316821005210/0001683168-21-005210-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"added"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ebdbb490d6","claim":"Andrew Telsey was appointed as Director at Sunshine Biopharma Inc..","evidence_excerpt":"The Board added Messrs. Andrew Telsey, JD Kish and Dr. Rabi Kiderchah to serve as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316821005210/0001683168-21-005210-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"added"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}